Colonial Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20M Sell
16,664
-391
-2% -$399K 2.53% 4
2026
Q1
$15.7M Sell
17,055
-349
-2% -$354K 2.13% 6
2025
Q4
$18.7M Sell
17,404
-200
-1% -$191K 2.49% 4
2025
Q3
$13.4M Buy
17,604
+94
+0.5% +$70K 1.81% 9
2025
Q2
$13.6M Sell
17,510
-433
-2% -$336K 1.99% 5
2025
Q1
$14.8M Sell
17,943
-193
-1% -$161K 2.3% 3
2024
Q4
$14M Buy
18,136
+254
+1% +$210K 2.08% 3
2024
Q3
$15.8M Buy
17,882
+262
+1% +$236K 2.44% 3
2024
Q2
$16M Sell
17,620
-232
-1% -$186K 2.81% 3
2024
Q1
$13.9M Sell
17,852
-655
-4% -$466K 2.6% 4
2023
Q4
$10.8M Buy
18,507
+966
+6% +$564K 2.25% 3
2023
Q3
$9.42M Sell
17,541
-1,460
-8% -$752K 2.33% 3
2023
Q2
$8.91M Sell
19,001
-662
-3% -$278K 2.13% 4
2023
Q1
$6.75M Sell
19,663
-341
-2% -$115K 1.72% 5
2022
Q4
$7.32M Sell
20,004
-1,149
-5% -$407K 2% 6
2022
Q3
$6.84M Buy
+21,153
New +$6.7M 2.18% 6

Other funds holding LLY

Colonial Trust's LLY Position: Q2 2026 in Review

Colonial Trust reduced its Eli Lilly (LLY) stake by 2.3% in Q2 2026, selling an estimated $399K and leaving 16,664 shares worth $20M. The position accounts for 2.53% of the portfolio, ranked #4.

Colonial Trust first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Colonial Trust held 16,664 shares of Eli Lilly worth $20M as of Q2 2026.
  • Colonial Trust sold 391 Eli Lilly shares in Q2 2026, an estimated $399K.
  • Eli Lilly made up 2.53% of Colonial Trust's portfolio in Q2 2026, its #4 holding.
  • Colonial Trust first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.